Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Cortical inhibition, facilitation and plasticity in late-life depression: effects of venlafaxine pharmacotherapy

Journal of Psychiatry and Neuroscience(2021)10.1503/jpn.200001Source: DataRank Database

Cortical inhibition, facilitation and plasticity in late-life depression: effects of venlafaxine pharmacotherapy is a research paper published in Journal of Psychiatry and Neuroscience (2021). On theSindex it has a DataRank of 0. It has been cited 15 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access15 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.94)OA: goldTopics (71)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Benoit H. Mulsant ORCID,Tarek K. Rajji ORCID,Jordan F. Karp ORCID,Charles F. Reynolds ORCID,Eric J. Lenze ORCID

Live enrichment

PubMed:33119493 OpenAlex:https://openalex.org/W3094912425

Canadian Institutes of Health Research

Grant: unidentified

unidentified

National Institutes of Health

Grant: 5R34MH101365-02

3/3 Buprenorphine for Late-Life Treatment Resistant Depression

NIMH NIH HHS

Grant: R34 MH101365

FWCI

0.94

Citation Percentile

0.7%

Citation Trend

2021

2023

2024

2025

goldLicense: cc-by-nc-nd

journalhttps://www.jpn.ca/content/jpn/46/1/E88.full.pdf

publisherhttps://www.jpn.ca/content/jpn/46/1/E88.full.pdf

publisherhttps://cdnsciencepub.com/doi/full-xml/10.1503/jpn.200001

publisherhttps://cdnsciencepub.com/doi/pdf/10.1503/jpn.200001

journalhttps://doi.org/10.1503/jpn.200001

Fields of Study

Transcranial Magnetic Stimulation StudiesNeurotransmitter Receptor Influence on BehaviorTreatment of Major Depression03 medical and health sciences0302 clinical medicineAgedAged, 80 and overMajor Depressive DisorderElectric StimulationElectromyographyEvoked Potentials, MotorFemaleHumansMaleMiddle AgedMotor CortexNeural InhibitionNeuronal PlasticityOutcome Assessment, Health CareSerotonin and Noradrenaline Reuptake InhibitorsTranscranial Magnetic StimulationVenlafaxine Hydrochloride

MeSH Terms

Serotonin and Noradrenaline Reuptake InhibitorsVenlafaxine HydrochlorideAgedAged, 80 and overDepressive Disorder, MajorMajor Depressive DisorderElectric StimulationElectromyographyFemaleHumansMaleMiddle AgedMotor CortexNeural InhibitionNeuronal PlasticityOutcome Assessment, Health CareEvoked Potentials, MotorTranscranial Magnetic Stimulation

Keywords

Transcranial magnetic stimulationAntidepressantNeuroplasticityNeurosciencePsychologyLate life depressionMajor depressive disorderVenlafaxineDepression (economics)FacilitationMotor cortexPrefrontal cortexMedicineStimulationCognitionHippocampusAged, 80 and overMaleNeuronal PlasticityElectromyographyVenlafaxine HydrochlorideNeural InhibitionMiddle AgedEvoked Potentials, MotorElectric StimulationOutcome Assessment, Health CareHumansFemaleSerotonin and Noradrenaline Reuptake InhibitorsResearch PaperAged

Sustainable Development Goals

SDG 0: Good health and well-being